Erin Quirk
President chez TERNS PHARMACEUTICALS, INC.
Fortune : 492 000 $ au 31/03/2024
Profil
Erin Quirk is currently the President and Head of Research & Development at Terns Pharmaceuticals, Inc. Prior to this, Dr. Quirk worked at Gilead Sciences, Inc. as the Vice President of HIV Clinical Research from 2010 to 2018.
Dr. Quirk completed their undergraduate degree at Drew University and their graduate degree at The University of Colorado.
They also obtained a doctorate degree from The University of Colorado School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/01/2024 | 75 000 ( 0,12% ) | 492 000 $ | 31/03/2024 |
Postes actifs de Erin Quirk
| Sociétés | Poste | Début |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | President | 07/02/2024 |
Anciens postes connus de Erin Quirk
| Sociétés | Poste | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/09/2018 |
Formation de Erin Quirk
| Drew University | Undergraduate Degree |
| The University of Colorado School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
